bims-mascan Biomed News
on Mass spectrometry in cancer research
Issue of 2026–10–18
24 papers selected by
Giovanny Rodríguez Blanco, Uniklinikum Graz



  1. Protein Sci. 2026 Nov;35(11): e70820
      Protein-nucleic acid (protein-Nu) interactions are crucial for many cellular processes and biological functions. Crosslinking mass spectrometry (XL-MS) has emerged as a powerful method for identifying these interactions. However, the analysis of protein-Nu XL-MS data requires an integrated workflow from raw data processing to results inspection and validation. Existing workflows for protein-Nu XL-MS often require switching between tools and considerable manual processing. Here, we introduce NuXLApp, an interactive web-based application for data processing and results visualization in protein-Nu XL-MS studies. NuXLApp integrates the protein-Nu crosslink search engine "NuXL," machine-learning models for peptide property prediction, and interactive result visualization within a reproducible workflow. It enables rapid validation of false discovery rate-controlled crosslink spectrum match-level identifications and facilitates collaboration and intuitive exploration of experimental results. In addition, NuXLApp generates a spectral library from identified protein-Nu crosslinks to enable quantitative analysis of crosslinks using data-independent acquisition (DIA). NuXLApp supports discovery-driven identification of protein-nucleic acid crosslinks and enables DIA-based follow-up experiments for their quantitative analysis. NuXLApp is open-source and available via the OpenMS WebApps platform at https://nuxl.webapps.openms.de/.
    Keywords:  computer science; data processing; false discovery rate; mass spectrometry; proteomics; raw data; search engine; visualization; web application; web application framework
    DOI:  https://doi.org/10.1002/pro.70820
  2. bioRxiv. 2026 Sep 30. pii: 2025.08.13.670166. [Epub ahead of print]
      We present a multi-organism, ground-truth metaproteomic dataset generated using data-dependent acquisition Parallel Accumulation-Serial Fragmentation (ddaPASEF) and data-independent acquisition (diaPASEF) on a trapped ion mobility mass spectrometer. The dataset comprises 28 species (30 strains) spanning Archaea, Bacteria, Eukarya, and bacteriophages, assembled into an uneven mock community with a 400-fold dynamic range of organismal abundance. Four biological replicates were processed using a standardized sample preparation workflow and analyzed using described LC-MS conditions. Raw data, search outputs, protein coverage metrics, quantitative abundance estimates, and strain-specific peptide evidence are provided. The dataset enables evaluation of proteome depth, proteome coverage, quantitative reproducibility, and strain-level resolution across acquisition strategies. diaPASEF yielded broader peptide and protein detection and deeper sequence coverage, while both methods accurately quantified high-abundance organisms. Detection evidence for low-abundance bacteriophages and single-amino-acid-variant peptides is included to support benchmarking of taxonomic and strain-resolved analyses. This dataset provides a comprehensive reference for developing and validating metaproteomic workflows, protein inference strategies, and ion mobility-aware computational tools.
    DOI:  https://doi.org/10.1101/2025.08.13.670166
  3. Methods Mol Biol. 2027 ;3071 57-80
      Recent advances in mass spectrometry instrumentation and computational analysis have established label-free data-independent acquisition (DIA) as a powerful tool in quantitative proteomics, offering depth, throughput, and reproducibility. These developments now enable large-scale projects with hundreds or even thousands of samples, opening new applications in systems biology and biomedicine. However, large-scale datasets require special consideration during data preprocessing. Here, we present a practical guide for preprocessing large-scale DIA datasets, illustrated using a public dataset. We cover key steps, including database searching, normalization, batch correction, missing value imputation, and evaluation of preprocessing strategies, and provide R code together with practical considerations.
    Keywords:  Batch effect correction; Data preprocessing; Data-independent acquisition (DIA); Label-free quantification; Large-scale proteomics; Missing value imputation; Normalization
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_4
  4. Anal Chim Acta. 2026 Nov 22. pii: S0003-2670(26)01181-5. [Epub ahead of print]1424 346231
       BACKGROUND: Statins are the most prescribed cholesterol-lowering drugs in the world. Reversed-phase ultrahigh-performance liquid chromatography coupled with tandem mass spectrometry (RP-UHPLC/MS/MS) enables the analysis of isomeric lipid species, and the chemical derivatization enhances ionization efficiency. Here, we address the need for a validated quantitative method for sterols and tocopherols in human plasma and its application for the characterization of statin-induced alterations in lipid composition at the level of isomeric species.
    RESULTS: We developed a high-throughput RP-UHPLC/MS/MS method using multiple reaction monitoring (MRM) in the negative ion mode, which is based on the chemical derivatization with 3-(chlorosulfonyl)benzoic acid. The optimized and validated method using eight internal standards (IS) was applied to NIST SRM 1950, which enabled the quantification of 18 sterol species and two tocopherols (α- and γ-tocopherols). The lipidomic profiling of human plasma samples obtained from 41 statin-treated and 41 statin-naïve subjects provided a broad overview of cholesterol-related lipids. The separation of sterol isomers was an essential aspect due to the varying statistical importance of individual isomeric species.
    SIGNIFICANCE: This methodology provides a highly sensitive and selective quantitative analysis of free sterol species and tocopherols with isomeric structural resolution, which is critical for biological interpretation. Univariate and multivariate statistical analyses demonstrated statistically significant alterations in the statin-treated cohort among endogenous free sterol species and α-tocopherol, while exogenous free sterols showed no statistically significant changes.
    Keywords:  Derivatization; Human plasma; Lipidomics; Mass spectrometry; Reversed-phase liquid chromatography; Statins; Sterol lipids
    DOI:  https://doi.org/10.1016/j.aca.2026.346231
  5. Methods Mol Biol. 2027 ;3071 17-28
      Proteomics datasets require detailed and standardized metadata annotation to ensure reproducibility, reusability, and alignment with FAIR (Findable, Accessible, Interoperable, Reusable) principles. This chapter presents a practical, hands-on workflow for annotating a label-free proteomics dataset using the Sample and Data Relationship Format for Proteomics (SDRF-Proteomics), a HUPO-PSI and EuBIC-MS standard that has been adopted by major proteomics data repositories. We demonstrate the process on a COVID-19 nasal-swab dataset (PXD020394), showing how to derive sample and assay metadata from the study files, encode them in SDRF with the lesSDRF web application, and validate the result. Although the worked example is label-free, the approach can be generalized to other quantification strategies.
    Keywords:  Annotation; COVID-19; FAIR; Mass spectrometry; Proteomics; SDRF; Sample metadata; lesSDRF
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_2
  6. Proteomics. 2026 Oct 15. e70195
      Proteomics is a powerful tool for profiling the protein landscape underlying cellular and physiological processes. Advances in mass spectrometry-based methods, such as tandem mass tags (TMT) isobaric labeling-based proteomics at both MS2 and MS3, label-free quantification (LFQ) with data-dependent acquisition (DDA) or data-independent acquisition (DIA)-based proteomics, and stable isotope labeling with amino acid (SILAC) spike-in-assisted proteomics, enable quantitative proteome comparisons across biological conditions. These five quantitative proteomic methods offer distinct advantages in coverage, throughput, and quantitative reproducibility. Here, we treated them as orthogonal approaches, retaining protein candidates with significant, consistent-direction changes supported across multiple independently instrumented methods to identify high-confidence protein-level changes associated with longevity. Insulin/insulin-like growth factor signaling (IIS) is a highly conserved longevity regulatory pathway from Caenorhabditis elegans to humans. By quantitatively profiling IIS mutants in C. elegans and performing genetic screening, we obtained a systems-view of proteomic changes linked to longevity and identified new longevity regulators. This systematic cross-method comparison also serves as a valuable resource for guiding the selection of quantitative proteomics approaches.
    Keywords:  LFQ‐DDA; LFQ‐DIA; SILAC; TMT; aging; longevity; mass spectrometry; proteomics
    DOI:  https://doi.org/10.1002/pmic.70195
  7. Bio Protoc. 2026 Oct 05. 16(19): e5584
      Extracellular vesicle (EV) proteomics can be used to study intercellular communication and find biomarkers of non-invasive diseases. Traditional separation methods (ultracentrifugation, size exclusion chromatography) and data-dependent acquisition (DDA) mass spectrometry usually have the drawbacks of copurification of pollutants, poor reproducibility, and insufficient sampling of low-abundance peptides. This protocol describes a workflow for label-free extracellular vesicle proteomics, which combines size exclusion chromatography for vesicle separation, data-independent acquisition (DIA) for deep discovery, and parallel reaction monitoring (PRM) for targeted verification. Plasma-derived extracellular vesicles are treated by standardized lysis, digestion, and LC-MS/MS procedures, so that the protein group of extracellular vesicles can be identified and quantified robustly. The main advantages of this scheme are that it can achieve high quantitative reproducibility, unbiased detection of low-intensity peptides, and seamless transition from discovery to targeted verification, while also being suitable for liquid biopsy samples and various cardiovascular diseases. Key features • Combines size exclusion chromatography (SEC)-based EV isolation with label-free data-independent acquisition (DIA) for deep, unbiased discovery-phase extracellular vesicle proteomics. • Employs parallel reaction monitoring (PRM) for orthogonal, highly sensitive targeted validation of candidate biomarkers discovered by DIA. • PRM records the entire, high-resolution fragment ion spectrum for the targeted peptide. • Developed for atrial fibrillation; adaptable to other cardiovascular diseases, therapy monitoring, and liquid biopsies.
    Keywords:  Biomarkers; Extracellular vesicles; Mass spectrometry; Parallel reaction monitoring; Proteomics
    DOI:  https://doi.org/10.21769/BioProtoc.5840
  8. Nat Methods. 2026 Oct 14.
      Here we present MassNet, inspired by large-scale data corpora of text and images; MassNet is an artificial intelligence (AI)-ready data corpus for mass spectrometry (MS)-based proteomics. The corpus contains 1.5 billion tandem MS spectra from high-quality data-dependent acquisition (DDA) MS data across 35 species. Approximately 1.7 million peptide precursors are from human samples. We further present an AI-ready DDA data format called Mass Spectrometry DDA Tensor (MSDT) for compact and standardized storage, curation and reuse of data from multiple sources, which can be optionally converted to a Lightning Memory-Mapped Database for accelerated input/output in deep learning. On the basis of MassNet, we develop XuanjiNovo, a nonautoregressive transformer model that leverages a curriculum learning strategy for de novo peptide sequencing. XuanjiNovo achieves 38.35-143.57% improvement over state-of-the-art methods on human Astral data. MassNet also supports additional downstream tasks, including retention time prediction and PSM rescoring. MassNet represents a foundational MS-based proteomics data resource, marking a critical milestone for AI proteomics research.
    DOI:  https://doi.org/10.1038/s41592-026-03247-y
  9. Methods Mol Biol. 2027 ;3071 113-126
      This chapter explains how to use ProtyQuant software to do label-free protein quantification in data-dependent acquisition (DDA) shotgun proteomics. Using the innovative "accumulated peptide probabilities" (APP) metric, it unifies protein inference and quantification, addressing significant issues in conventional workflows. The protocol gives a step-by-step guide that starts with preparing raw mass spectrometry data and searching databases. It then moves on to validating peptides and ends with using ProtyQuant to infer proteins and estimate their amounts. It further outlines the optional postprocessing analysis using R. Emphasizing reproducibility and accessibility, the entire workflow is integrated within MASSyPupX, a free and open-source Linux distribution, enabling researchers to perform high-throughput proteomics studies efficiently from a portable USB drive. This guide is designed to empower researchers in academic, clinical, and industrial settings to generate statistically robust and interpretable protein abundance data.MASSyPupX can be accessed via Zenodo ( https://doi.org/10.5281/zenodo.14618430 ) and its project page ( https://codeberg.org/LabABI/MASSyPupX ).
    Keywords:  Comparative analysis; Data-dependent acquisition; Label-free quantification; Mass spectrometry; Protein inference; ProtyQuant; Shotgun proteomics
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_7
  10. Methods Mol Biol. 2027 ;3084 45-76
      Altered metabolism is a hallmark of cancer, where rewiring of cellular metabolic pathways is essential for tumor initiation, support of rapid proliferation, and adaptation to new metastatic sites. Metabolomics has emerged as a powerful tool to comprehensively characterize the metabolome of cancers and holds promise to transform understanding of how oncogenes can drive tumorigenesis and metastasis, identify cancer-specific metabolic dependencies, and provide novel therapeutic opportunities. This chapter describes methods to extract metabolites from Ewing sarcoma (EwS) cells grown in 2D or 3D cultures and from EwS mouse xenograft tissues, and to broadly analyze these compounds using an untargeted metabolite profiling approach. This methodology is likely applicable to a wide range of cultured cell and tissue types.
    Keywords:  Ewing sarcoma; Liquid chromatography mass spectrometry; Spheroids; Tumor; Untargeted metabolomics; Xenograft
    DOI:  https://doi.org/10.1007/978-1-0716-5587-0_4
  11. Methods Mol Biol. 2027 ;3071 97-112
      Protein identification by mass spectrometry (MS) is a pivotal step in proteomics. Numerous methods have been developed to securely and effectively identify proteins derived from experimentally detected peptides by mass spectrometry. The dominant approach is based on the assumption that each experimentally identified peptide can be matched with a peptide included in a database of peptide sequences, generated by in silico digestion of proteins with a specific proteolytic enzyme. In this way, the protein containing the peptide can be identified. In a more advanced approach, the proteins and their in silico-digested peptides in the database are transformed into theoretical mass spectrometry spectra, and search engines match the experimentally obtained spectra to these theoretical spectra generated from protein and peptide sequences. We developed an alternative method for protein identification using Core Unique Peptides (CrUPs) and the Uniquome, termed as Uniquome-Based Protein Identification Method (UB-PIM). According to this method, instead of searching for peptides in the database of in silico-digested peptides, we search for CrUPs within the experimentally obtained peptides by mass spectrometry. If a peptide contains at least one CrUP, it can be directly correlated to the protein from which the CrUP is derived. Because of the unique nature of CrUPs, peptides obtained by MS can securely and uniquely identify the protein of origin. This provides a reference space in which even single-peptide identifications can achieve high specificity, reducing the ambiguity caused by shared or homologous sequences and improving the interpretability of MS data. Furthermore, UB-PIM can be applied to any type of peptide and is effective with both Data-Independent Acquisition (DIA) and Data-Dependent Acquisition (DDA) approaches, as well as with top-down and bottom-up proteomics. This allows confident protein identification from minimal evidence, expands the scope of detectable proteins, and remains computationally efficient, rapid, and universally applicable.
    Keywords:  Core Unique Peptides; Mass spectrometry; Protein identification method; UB-PIM; Uniquome; Uniquome-based method
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_6
  12. Methods Mol Biol. 2027 ;3071 309-336
      We present a simple, practical workflow for annotating tandem mass spectrometry (MS/MS) data of small molecules using advanced machine learning and a reference library. The discovery and structural characterization of small molecules is central to biology, chemistry, and medicine. MS/MS has become the leading technology for this task, yet the majority of spectra from untargeted metabolomics remain unannotated, limiting our understanding of the underlying chemical diversity. Artificial intelligence (AI) is rapidly reshaping many areas of science, and mass spectrometry is no exception. In this chapter, we introduce a practical workflow for annotating MS/MS data using two complementary resources: DreaMS, a foundation model for mass spectrometry, and MassSpecGym, a large reference library and benchmarking platform. DreaMS embeds mass spectra into a representation space where structural similarity is preserved, and MassSpecGym provides anchor points for retrieving identical or related molecules. Together, they form an ecosystem that enables efficient annotation of experimental MS/MS data. We demonstrate this approach on alkaloid data from Piper fimbriulatum, showing how DreaMS can retrieve exact matches or place unannotated spectra alongside structurally related compounds. All steps are provided as easy-to-follow protocols, designed to run on standard hardware and requiring no modifications to existing metabolomics pipelines. Readers will learn how to integrate AI tools into their own workflows for compound annotation, molecular networking, and discovery. Overall, this chapter aims to empower biologists and chemists to harness machine learning for metabolomics, transforming unannotated spectra into interpretable chemical knowledge.
    Keywords:  Foundation model; Mass spectra embeddings; Mass spectrometry; Retrieval; benchmark
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_14
  13. Methods Mol Biol. 2027 ;3071 189-204
      This chapter presents concepts, guidelines, and data processing procedures for the analysis of targeted and untargeted proteomics data in bioengineering contexts. The pipelines have been successfully demonstrated in microbial systems such as Rhodotorula toruloides, Pseudomonas putida, and Aspergillus niger. The methods described in these workflows involve popular open-source software tools and downstream algorithms that enhance data annotation, quantification, and reproducibility. These procedures can be used to quantify metabolic pathway enzymes and validate engineered strains. While focused on bioengineering applications, most of these procedures apply to any proteomics study. The chapter uses published data and step-by-step guides to allow researchers unfamiliar with the approach to successfully execute the techniques.
    Keywords:  Bioengineering; DDA; DIA; FAIR data; FAIR software; LC; Mass spectrometry; SRM
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_10
  14. Methods Mol Biol. 2027 ;3071 3-16
      Mass Spectrometry Data Management System (MSDMS) is a comprehensive software solution for managing small molecule mass spectrometry (MS or MS/MS) libraries in MassBank format. Starting from large public libraries, MSDMS enables the creation of one or more custom libraries without having to run reference compounds or manage unknowns. Custom libraries improve the quality and speed of identification by LC-MS/MS screening of exogenous and endogenous compounds in complex biological samples. With a container-based architecture and Docker Compose configuration, MSDMS can be deployed as a website or as a local software application. Its use is explained in a stepwise manner and illustrated with human urine sample screening.
    Keywords:  Drug of abuse; Libraries; MS/MS; Mass spectrometry; MassBank; Metabolites
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_1
  15. Mol Cell Proteomics. 2026 Oct 13. pii: S1535-9476(26)00095-2. [Epub ahead of print] 101599
      In this study, we systematically evaluated the nanoLC-Zeno TOF platform using data-independent acquisition (DIA) and identified 3,142 to 7,059 protein groups from 1 to 200 ng of standard K562 digest. Additionally, a targeted acquisition strategy detected 184 peptides with enhanced signals using Zeno activation. To achieve cell type-resolved spatial proteomics, we developed a workflow integrating image-guided laser capture microdissection for the analysis of gastric cancer tissue. A 30-minute nanoLC gradient facilitated the quantification of 2,514 proteins from 0.2 mm2 regions representing cancer cells, cancer-associated fibroblasts (CAFs), and immune cells, as defined by multiplex immunohistochemistry (mIHC). This spatial proteomics approach revealed cellular heterogeneity within the tumor microenvironment of a clinical gastric cancer sample, and targeted validation identified the differential expression of 12 cancer-associated proteins comprising 103 peptides between cancer cell-enriched and CAF-enriched regions. This workflow offers a practical strategy for spatial proteomic analysis of clinical tissue samples.
    Keywords:  DIA; Gastric Cancer; Spatial Proteomics; Targeted Proteomics; Zeno TOF 7600; nano-LC
    DOI:  https://doi.org/10.1016/j.mcpro.2026.101599
  16. ACS Chem Biol. 2026 Oct 15.
      Polyunsaturated fatty acids (PUFAs) are essential nutrients supporting numerous cellular processes in normal and neoplastic cells, yet PUFA-containing phospholipids predispose cells to ferroptosis. How cancer cells from various lineages or genetic backgrounds proliferate in the presence of PUFA remains poorly understood. Here, by systematically profiling various fatty acids using a barcoded and pooled cancer cell line library, we show that a subset of cell lines is sensitive to PUFA treatment at concentrations comparable to physiological levels. We demonstrate that PUFA treatment alone is sufficient to induce ferroptosis in these cell lines that are also vulnerable to GPX4 inhibition. By correlating patterns of PUFA sensitivity with cancer cell line features including basal mRNA transcript levels, we show that PUFA sensitivity is positively associated with fatty acid binding protein 1 (FABP1) expression. Additionally, by profiling a diverse collection of fatty acids and analogs, we find that ferroptosis in cancer cells can be effectively induced by conjugated linolenic acids, in addition to PUFAs containing 1,4-pentadiene groups. Genome-wide CRISPR modifier screens in the PUFA-sensitive ES2 cells reveal a pro-ferroptosis pathway defined by enzymes that convert PUFAs to membrane-associated phospholipids, and an anti-ferroptosis pathway that segregates PUFAs by delivering them to lipid droplets. Together, we present the first comprehensive data set of PUFA-induced ferroptosis sensitivity in a collection of 554 cell lines from 19 primary lineages and suggest a potential therapeutic avenue to induce tumor cell ferroptosis using dietary metabolites.
    DOI:  https://doi.org/10.1021/acschembio.6c00581
  17. Methods Mol Biol. 2027 ;3071 235-308
      Analytical chemistry, and particularly mass spectrometry (MS), plays a central role in the molecular characterization of biological and environmental samples. These data are essential for understanding the molecular mechanisms underlying healthy aging, disease onset and progression, and the complex chemical composition of environmental systems. Over the past decades, MS has undergone unprecedented technological advancements. Current state-of-the-art instruments enable the  thorough characterization of deep proteomes at the single-cell level and achieve comprehensive coverage of metabolites and proteins. Innovations such as new mass analyzers (e.g., the Astral mass analyzer) and the integration of multidimensional separation techniques (e.g., trapped/cyclic ion mobility) have significantly expanded the analytical capabilities of the instrumentation. However, the volume and complexity of the data produced by these advanced platforms pose major challenges for interpretation and integration. To address these challenges, machine learning (ML) and artificial intelligence (AI) methods are emerging as indispensable tools in analytical chemistry. These approaches, particularly deep learning, generative AI, and large language models, offer powerful solutions for analyzing, integrating, and interpreting the high-dimensional, heterogeneous datasets generated in proteomics and metabolomics research. This chapter first introduces the fundamental principles and operational mechanisms of commonly used AI/ML methods in analytical chemistry. These include regression models, decision trees, k-nearest neighbors, support vector machines, neural networks, deep learning architectures, and generative AI. The first part of the chapter also discusses key requirements for model training, including the need for sufficient sample and molecular coverage, and evaluates how data noise affects model performance and reliability. In the second part, a series of representative applications are presented, demonstrating the use of AI/ML for peptide and metabolite observability prediction, retention time and ion mobility prediction, fragment ion spectrum generation, de novo compound identification, and improvements in compound quantification and scoring of identifications. The chapter concludes with practical recommendations for applying AI/ML approaches in proteomics and metabolomics studies, and for their integration into bioinformatics pipelines to enhance data interpretation, reproducibility, and scientific discovery.
    Keywords:  Artificial intelligence; Deep learning; Machine learning; Mass spectrometry; Metabolomics; Proteomics
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_13
  18. Methods Mol Biol. 2027 ;3071 337-351
      Increasing complexity and volume of mass spectrometry (MS) data have presented new challenges and opportunities for peptide identification in shotgun proteomics. Existing database search algorithms reduce the number of potential candidate peptides by using precursor mass filtering. While useful, relying on a single and simple filter may lead to the exclusion of nonabundant spectra and uncharacterized peptides. In this chapter, we present a machine-learning model, called ProteoRift, capable of predicting multiple properties of the peptide (e.g., length, missed cleavages, and modification status) directly from the spectra. Predicting multiple properties helps to apply more targeted filters in the database search and provides up to 12× speedup as compared to mass-only filtering in peptide identification. This chapter describes the general architecture, which is followed by a step-by-step guide for installing and performing database searches using the ProteoRift model. Lastly, we discuss the data preparation and preprocessing steps required for retraining ProteoRift. ProteoRift is an open-source and open-weights model and is available at https://github.com/pcdslab/ProteoRift.
    Keywords:  Database search; Deep learning; MS data processing; MS/MS analysis; Machine learning; Peptide identification; Proteomics
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_15
  19. J Cheminform. 2026 Aug 10. pii: 142. [Epub ahead of print]18(1):
      Reliable quality control of mass spectrometry data remains a major bottleneck in target, suspect and non-target screening workflows. In non-target analysis, thousands of features can be extracted through automated peak picking, many of which require manual verification to exclude artefacts arising from noise, co-elution, inconsistent chromatographic behavior or statistical prioritization. Similarly, suspect screening workflows depend on effective chromatographic and spectral quality control to support confidence in annotated features. However, existing quality control practices are often fragmented across vendor software and custom scripts, limiting reproducibility and scalability. This article describes pyMSscreen, a unified framework that enables automated and reproducible chromatographic quality control across target, suspect, and non-target mass spectrometry workflows. The backend leverages RDKit and pyOpenMS for compound validation and spectral extraction, while the frontend provides a web-based interface for systematic inspection of chromatograms and mass spectra. The development of pyMSscreen draws on experience gained from the earlier R-based Shinyscreen, which showed that accessible graphical user interface can greatly simplify the review of liquid chromatography mass spectrometry data. However, the practical limitations of the Shiny framework, including difficulties with deployment, motivated the creation of a more flexible and modern solution. pyMSscreen employs a modular architecture that supports target, suspect, and non-target screening by accommodating both SMILES or m/z only input lists. Automated quality control metrics are applied consistently across workflows, enabling assessment of peak shape, signal intensity, retention-time alignment, and background noise prior to downstream interpretation. Container-based deployment ensures reproducible installation and execution across computational environments. The performance and applicability of pyMSscreen is illustrated using a representative non-target dataset and suspect screening workflow demonstrating consistent results relative to established approaches, while substantially reducing manual data handling and review time. Overall, pyMSscreen provides an efficient, transparent, and reproducible platform for chromatographic quality control and data curation in high resolution mass spectrometry based cheminformatics workflows. The code is openly available (Artistic 2.0 license) at https://gitlab.com/uniluxembourg/lcsb/eci/pymsscreen .Scientific contributionpyMSscreen presents a unified framework for chromatographic quality control that integrates automated quality metrics with interactive visual inspection of mass spectrometry data. The central contribution is the consistent evaluation of chromatographic peak quality and spectral alignment across target, suspect, and non-target screening workflows within a single methodology. This work builds on earlier developments in interactive mass spectrometry data review while establishing a scalable and reproducible approach to feature-level quality control.
    Keywords:  Docker; High resolution mass spectrometry; Interactive visualisation; Non-target screening; Open source software; Quality control; Spectral data analysis
    DOI:  https://doi.org/10.1186/s13321-026-01260-z
  20. Talanta. 2026 Oct 13. pii: S0039-9140(26)01426-8. [Epub ahead of print]313(Pt A): 130770
      Medicinal plants and fungi produce numerous structurally diverse metabolites, and many of these occur as isomers that are challenging to differentiate. Consequently, when mass spectrometry imaging (MSI) is used to spatially localize these compounds, annotation accuracy suffers from isobaric and isomeric interferences that accurate mass alone cannot resolve. To address this, we established an integrated spatial metabolomics strategy combining an optimized tape-assisted frozen section protocol, desorption electrospray ionization ion mobility mass spectrometry imaging (DESI-IM-MSI), and a cross-platform annotation workflow. The frozen section protocol was evaluated through blank control and repeated experiments, showing minimal background interference. In the annotation workflow, metabolites are first annotated in tissue extracts by liquid chromatography ion mobility mass spectrometry (LC-IM-MS), and then matched to DESI-IM-MSI images through shared drift time and m/z values. This enables orthogonal validation of metabolite annotations using retention time, drift time, and MS/MS fragmentation data. Applying this strategy to four plants (Ginkgo biloba, Panax ginseng, Scrophularia ningpoensis, and Salvia miltiorrhiza) and one fungus (Ganoderma lingzhi) enabled the first simultaneous imaging of multiple isomeric metabolites, including ginkgolide J and C, each resolved from its isomers. These isomers exhibited distinct tissue-specific distributions across these species. This strategy also reduced misannotations and resolved positional isomers, isobaric compounds, and background interferences that were indistinguishable by conventional MSI. This integrated workflow provides a practical approach for isomer-resolved spatial metabolomics across chemically complex plant and fungal matrices.
    Keywords:  DESI-IM-MSI; Ion mobility mass spectrometry; Isomer separation; Mass spectrometry imaging; Spatial metabolomics
    DOI:  https://doi.org/10.1016/j.talanta.2026.130770
  21. Methods Mol Biol. 2027 ;3071 127-165
      Posttranslational modifications (PTMs), particularly phosphorylation, regulate protein function at substoichiometric levels, making their quantitative analysis technically challenging. A critical limitation in PTM studies is distinguishing between changes in modification abundance due to altered protein expression versus genuine changes in modification stoichiometry (the fraction of protein molecules that are modified). This chapter presents a comprehensive workflow integrating Tandem-Mass-Tag (TMT)-based quantitative proteomics with specialized computational analysis to distinguish differential PTM abundance (DPA) from differential PTM usage (DPU) using the prolfqua, prolfquapp, and prophosqua R packages. The workflow introduces a robust statistical framework for integrated PTM-protein analysis; comprehensive visualization tools, including N-terminus to C-terminus (N-to-C) plots for protein-centric PTM mapping and sequence motif analysis for kinase prediction. This integrated approach enables researchers to identify actual signaling changes in PTM studies, prioritize functionally relevant modification sites, understand pathway-level regulation in disease contexts, and generate robust datasets suitable for publication in high-impact journals.
    Keywords:  Data integration; Differential PTM abundance analysis; Differential PTM usage analysis; Kinase activity; Mass spectrometry; Phosphoproteomics; Posttranslational modifications; TMT labeling
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_8
  22. Methods Mol Biol. 2027 ;3071 81-95
      We present the R/Bioconductor PSMatch package, which helps proteomics practitioners to load, manage, and handle peptide spectrum matches. It provides functions to model peptide-protein relations, visualize these as graphs, and make informed decisions about shared peptide filtering. The package also provides functions to calculate fragments and, in conjunction with the Spectra package, annotate and visualize MS2 scans.
    Keywords:  Bioconductor; Identification; Mass spectrometry; PTM; Proteomics; R; Reproducible research; Software; Visualization
    DOI:  https://doi.org/10.1007/978-1-0716-5519-1_5
  23. bioRxiv. 2026 Sep 28. pii: 2026.09.25.754519. [Epub ahead of print]
      Subcellular mass spectrometry imaging (MSI) has required specialized instrumentation and approaches. Additionally, data analysis has required expensive proprietary software, or code-based open-source tools. These barriers render spatial metabolomics less accessible than peer spatial omics techniques (transcriptomics, proteomics). Here we demonstrate subcellular MSI on standard commercial hardware, analyzed using code-free, open-source software. An inexpensive, fully reversible modification of a stock DESI source takes the platform past its typical 5-10 μm pixels to routine 2x2 μm pixels, and 1x1 μm in proof-of-principle experiments. At a tissue-glass boundary imaged at 2x2 μm, tissue-specific ions showed no measurable spillover onto the adjacent glass within the ±4.4 μm uncertainty of the edge position. To make these data interpretable, we extend MSI.EAGLE, an open-source, vendor-agnostic application with two new methods: i) Spatial UMAP preserves tissue architecture alongside subcellular detail, where conventional clustering breaks apart at high resolution; ii) Histology Fit performs landmark-free co-registration, and recovers synthetic misalignments of up to 8 μm to within one pixel of a reference registration. Together, these enable previously high-burden spatial metabolomics experiments. In mouse brain tissue, we demonstrate genuine subcellular signal by resolving mitochondrial cardiolipin into perinuclear puncta, quantifying cytoplasmic enrichment across 6,073 cells. Cell identities are assigned to MSI pixels using histology-predicted transcriptomics, linking cell provenance to metabolism in 2D space directly. Finally, we recover cell-type-specific metabolomes consistent with the transcriptomic identities. This workflow allows cellular and subcellular spatial metabolomics linked to cell provenance, with only stock MSI hardware, open-source GUI-based software, and common histology techniques, putting it within reach of many researchers and laboratories.
    DOI:  https://doi.org/10.64898/2026.09.25.754519
  24. Anal Chim Acta. 2026 Nov 22. pii: S0003-2670(26)01187-6. [Epub ahead of print]1424 346237
       BACKGROUND: In metabolomics studies, biological data are highly complex, requiring robust computational tools to detect biological variation in the organism under investigation. Despite this, comparative studies of data processing software for GC-MS data are scarce. This work evaluated the performance of two open-source software programs, XCMS and MS-DIAL, on three datasets: cells, serum, and tissue, acquired by GC-MS.
    RESULTS: Software performance was assessed based on the quality of the raw data matrix, the number of extracted features, the presence of missing values, and the number of annotated metabolites or chemical classes. Overall, both tools produced robust matrices and adequate statistical models, with high similarity in the regulation of common metabolites. For the investigated datasets, XCMS demonstrated slightly better performance in raw matrix quality, while MS-DIAL showed a higher correlation with the annotations. The combination of matrices broadened metabolic coverage, allowing for improvements in supervised statistical models. The choice of data processing platform and the parameters used directly impact the extracted data matrix and the conclusions regarding metabolic alterations.
    SIGNIFICANCE: These observations reinforce the need for careful evaluation in metabolomics analyses, so that selection involves not only parameters such as the number of features and metabolites obtained, but also the method's stability and its ability to show the chemical variability of the analyzed biological system.
    Keywords:  Bioinformatics; Data processing; MS-DIAL; Metabolite annotation; Metabolomics; Peak detection; XCMS
    DOI:  https://doi.org/10.1016/j.aca.2026.346237